Connect with us


“Quality Healthcare”: Visuals Contradict Madhya Pradesh Policy Promise – dot newz



A video showed four persons, two new mothers and their babies, on a bed at a Shajapur hospital.


The Madhya Pradesh government’s health care policy says “irrespective of age, gender, and place” people have the right to access high quality and affordable healthcare. A series of disturbing visuals that have emerged in the past few days from various parts of the state, however, call out the hollowness of the claim.

Last week, a video clip began making the rounds on social media showing the conditions inside the maternity ward of the district hospital in Shajapur, around 156 kilometres west of Bhopal.

It had four persons — two new mothers and their babies — on one bed. Bearing immense pain following delivery, the women were strapped for space. Their relatives slept on the floor besides them.

“In these times of corona, proximity to other patients scares us, but we have no choice. My daughter is admitted,” said one such relative, too scared to reveal her identity.

Acknowledging a bed crunch, Dr BS Maina, a civil surgeon at the hospital, merely said, “The scarcity is being addressed.”

In another video, a body was seen being transported in a garbage disposal vehicle in Umaria district, some 423 kilometres east of the capital. The person had succumbed to injuries at the Chandia Community Health Centre (CHC).


Earlier, the ambulance linked to 108 service arrived late to ferry him and wife — she survived the accident, though — to the hospital. This delay may have been one of the reasons for his death.

Dr RK Mehra, the Umaria District Chief Medical and Health Officer, admitted that dedicated vehicles to carry the dead are available only at the district hospital and at a couple of other facilities.

The third incident was reported on Independence Day from Satna district, around 440 kilometres northeast of Bhopal.

Neelam Adivasi gave birth to a baby on a muddy pathway as the ambulance couldn’t reach her village due to the poor road condition.

“My wife had labour pain on Sunday. I called Janani Express in the morning but the ambulance reached almost 2-3 hours late. Then the driver said he couldn’t drive to the village due to the poor condition of the road. We were left with no option but to cover around two kilometres on foot,” Adivasi’s husband Pankaj Adivasi said.

The tribal woman delivered before reaching the ambulance. She was then taken to the hospital in that vehicle.

“The ambulance driver and attendant safely brought the woman and her baby to the hospital. Now, they are absolutely fine,” Block Medical Officer Dr Sarvesh Singh said.

In another case, last Friday, the staff at the Jhiri Village Model Primary Health Centre in Shivpuri, over 300 kilometres north of Bhopal, helped a pregnant woman deliver — the hospital room lit up with candles and torches.


The power supply to the facility had been disrupted for eight days by then due to floods, officials said. The hospital’s Auxiliary Nursing Midwife said she had informed her superiors about the power problem. The mother and the baby remain healthy, she said.

The Central government’s guidelines for public health centres say they must have power backup.

Such community and primary health centres are often life savers for India’s rural population. These incidents prove that the Madhya Pradesh government health care sector’s condition is anything but healthy. The Central government’s figures show it is among the top five states with the highest shortfall of surgeons at 302.

There is also a 28 per cent shortage of public health centres and a 37 per cent shortage of community health centres in the state’s hinterlands.

Of its 52 district hospitals, only 14 have functioning CT scan machines. Twenty-three of the 1,280 ventilators available in its 13 government medical colleges are non-functional.

When NDTV asked state Health Minister Dr Prabhuram Chaudhary about the sorry visuals, he said, “We can’t be negative all the time.”

Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Amarinder Singh On Backfoot? Congress Calls Key Meeting Of Punjab MLAs – dot newz




The 117-member Punjab assembly will vote early next year (File)

New Delhi:

There is fresh sparking in the Punjab unit of the Congress. Citing “representation from a large number of MLAs”, the Congress, in a late night tweet, has called for a key meeting of its Punjab legislators today.

“The AICC has received a representation from a large number of MLAs from the Congress party, requesting to immediately convene a meeting of the Congress Legislature Party (CLP) of Punjab. Accordingly, a meeting of the CLP has been convened at 5 PM on September 18 at Punjab Pradesh Congress Committee office.

“AICC directs the PPCC to facilitate this meeting. All congress MLAs of Punjab are requested to kindly attend this meeting,” Harish Rawat, Congress’s Punjab in-charge, tweeted Friday night.

Mr Rawat also tagged Congress leader Rahul Gandhi, Chief Minister Amarinder Singh and Punjab Congress chief Navjot Singh Sidhu in his tweet.

Navjot Sidhu, who continues to take potshots at his Chief Minister, retweeted Harish Rawat, then tweeted, and repeated, that a meeting has been called.

“As per the AICC directive, Congress Legislature Party meeting has been convened at @INCPunjab PPCC Office, Chandigarh on 18 September 2021 (Saturday) 5 PM,” said Mr Sidhu.

Harish Chaudhary and Ajay Maken will be the central observers for the Punjab meeting.

There has been no reaction from Captain Amarinder Singh so far.

Last month, four ministers and around two dozen party legislators had raised a squadron of complaints against the Punjab Chief Minister and said that they had no faith in his ability to honour poll promises.

The Congress has been papering over the differences between the two top leaders in the state unit, telegraphing a message of unity and cooperation.

As recently as September 8, Mr Rawat, speaking to news agency ANI, said that the people assume party leaders in Punjab are fighting because the ”brave” leaders put forward their opinion strongly.

“Punjab is the land of braves. People there put their opinion very strongly there and it looks like they will fight. But, there is nothing like that, and they find solutions to their problems. Punjab Congress is solving their issues themselves. We are not doing anything,” the Congress leader said.

When asked about the relation between Amarinder Singh and Mr Sidhu, Mr Rawat said, “If there would be a dispute, it would be good for Congress.”

The BJP, in a sharp contrast, has replaced four chief ministers in six months. Most recently Vijay Rupani quit as Gujarat Chief Minister a year ahead of polls.. His resignation follows that of BS Yediyurappa in Karnataka in July and a double blow in Uttarakhand, where Tirath Singh Rawat quit barely four months after replacing Trivendra Rawat.

Both Gujarat and Uttarakhand will vote for new governments next year.

Cricketer-turned-politician Navjot Singh Sidhu was declared the Punjab Congress chief in July after weeks of infighting and in face of strong opposition by Captain Amarinder Singh. He has been a vehement critic of the state government.

Even after a month of assuming the new role, Mr Sidhu keeps pulling up the government for not fulfilling the pre-poll promises.

The Congress, which has only a skinny group of states in its kitty, has been battling leadership issues in Punjab, which is quickly turning into a political sinkhole for the grand old party.

The 117-member Punjab assembly will vote early next year.

Source link

Continue Reading


Coronavirus Live News Update: India Creates World Record In Vaccinations With 2.5 Crore Doses In A Day – dot newz




The government had set out with a target of 2.5 crore vaccinations and crossed the mark by 10,390

India crossed 2.5 crore Covid vaccinations in a day for the first time on Friday as the government raced to deliver a record on Prime Minister Narendra Modi’s birthday. Union Health Minister Mansukh Mandaviya tweeted to confirm the “historic” figure.

The government had set out with a target of 2.5 crore vaccinations and crossed the mark by 10,390.

With 34,403 more people testing positive for COVID-19, India’s overall infection tally has increased to 3,33,81,728, while the count of active cases has dipped to 3,39,056, according to Union health ministry data updated on Friday.

The death count due to the disease has climbed to 4,44,248 with 320 more fatalities being recorded, it said.

The number of active cases now comprises 1.03 per cent of the total infections, while the national COVID-19 recovery rate has been recorded at 97.64 per cent, according to the data updated by the ministry.

It said that active COVID-19 cases in the country decreased by 3,867 cases in a span of 24 hours.

Here are the updates on coronavirus (COVID-19) cases:

Over 7 lakh people vaccinated in Assam on PM’s birthday

A total of 7,09,524 people received the COVID-19 vaccine in Assam on Friday as the state government undertook a mega inoculation drive on the occasion of Prime Minister Narendra Modi’s birthday, a bulletin said.

Over 2.16 crore people have been immunised, and 44.02 lakh of them got both doses of the vaccines, it said.

The special drive was conducted in 4,575 COVID Vaccination Centres (CVCs), of which 4,557 were government sites and 18 private ones.

Source link

Continue Reading


WHO Emergency Approval For Covaxin Delayed Till October 5 – dot newz




The assessment of the SAGE working group on the available pieces of evidence will determine EUA.

New Delhi:

World Health Organisation’s (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.

As per WHO, the Strategic Advisory Group of Experts on Immunization (SAGE) will be meeting on October 5 to granting EUA to Covaxin.

Hanna Nohynek, SAGE member will be introducing session objective setting, an update on regulatory decisions and an overview of Working Group deliverables.

The session will recommend EUA based on the clinical data on Covaxin from phase 1, 2, 3 trial and post-marketing studies on safety, immunogenicity, efficacy and effectiveness.

It will update on global, regional and country-level plans for vaccine safety monitoring.

The assessment of the SAGE working group on the available pieces of evidence will determine EUA.

Meanwhile, Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency.

In a series of tweets, Bharat Biotech said that Covaxin clinical trial was fully compiled and available in June 2021.

“#COVAXIN clinical trial data was fully compiled and available in June 2021. All Data was submitted for Emergency Use Listing (EUL) Application to World Health Organization in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback,” Bharat Biotech tweeted.

As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on the approval process and its timelines, it further said.

“We are continuing to work diligently on obtaining WHO EUL at the earliest,” it added.

Bharat Biotech has submitted its Phase 3 clinical trials data that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

Covaxin was developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology. Covaxin, which has been developed in collaboration with the Indian Council of Medical Research (ICMR), contains a whole virion inactivated SARS-CoV-2 vaccine, which is produced in Vero cells.

The vaccine is stable at 2 degrees Celsius to 8 degrees Celsius (refrigerated) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels.

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Source link

Continue Reading


Copyright © 2017 Dot Newz | Developed by MCVP Group 8